CXCR4 and breast cancer: The seven amino acids long JM173 peptide should mediate the targeted delivery of the therapeutic cargo molecule C3bot1 toxin (indicated in this context as C3) into the cytosol of CXCR4 overexpressing breast carcinoma (BC) cells.